Related Experiment Videos
Immunohistochemical study on pigmented nevi (preliminary communication)
V Sarafian1, Y Topov, D Mircheva
1Department of Biology, Medical University, Plovdiv, Bulgaria.
Folia Medica
|January 1, 1994
Summary
This study investigated human blood group antigens, cytokeratin, S-100 protein, and melanoma-associated antigen in pigmented nevi. Findings reveal specific antigen expressions that may indicate potential malignant development in Spitz nevi.
Area of Science:
- Dermatopathology
- Immunohistochemistry
- Oncology
Background:
- Pigmented nevi, including Spitz nevi, are common skin lesions.
- Understanding their immunophenotype is crucial for distinguishing benign from malignant lesions.
- Specific antigens may offer insights into the potential for malignant transformation.
Purpose of the Study:
- To analyze the expression of human ABH blood-group antigens, cytokeratin, S-100 protein, and melanoma-associated antigen in pigmented nevi.
- To investigate the immunologic traits of Spitz nevi.
- To assess antigens potentially linked to malignant development.
Main Methods:
- Utilized the biotin-streptavidin immunostaining system.
- Examined 12 cases of pigmented nevi.
- Evaluated the expression patterns of selected antigens within different cellular components of the nevi.
Main Results:
- ABH antigens were detected in endothelial cells and the germinative epidermal layer.
- Cytokeratin positivity was observed in the overlaying epithelium, melanocytes, and melanoblasts.
- S-100 protein stained basilar cells and giant multinucleate cells in Spitz nevi.
- Melanoma-associated antigen was visualized in upper epidermal layers and some melanocytes.
Conclusions:
- The study characterized the expression of key antigens in pigmented nevi.
- Specific immunophenotypic profiles were identified in Spitz nevi.
- The findings contribute to understanding the immunologic markers associated with potential malignant development in Spitz nevi.